USPTO Trademark Record
PENDINGREVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE
SN 99539881·Reg 0·Filed Dec 10, 2025
Owner Sam Shrivastava
Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.
REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE (Serial No. 99539881), Registration No. 0, is a pending US trademark filed on Dec 10, 2025 by Sam Shrivastava. This trademark covers Class 042 (Scientific, technology & SaaS services).
